Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any malignant glioma in which the cause of the disease is a mutation in the PTEN gene.
Features include always present findings: Oligodendroglioma and Meningioma.
Biomarker and diagnostic research for glioma susceptibility 2 has been reported in the published literature.
Phenotype severity distribution: 2 always present features.
No clinical trials have been registered for glioma susceptibility 2.
253 publications have been identified in PubMed for glioma susceptibility 2. Research spans Basic Science / Preclinical (37%), Review / Meta-Analysis (20%), and Diagnostic / Biomarker (16%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 94 | 37% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 6:47 AM UTC
Online Mendelian Inheritance in Man
50 |
20% |
Testing and diagnosis research | 40 | 16% |
Disease patterns and progression | 28 | 11% |
New treatment approaches | 17 | 7% |
Patient case studies | 12 | 5% |
Clinical study results | 12 | 5% |
Kegoya Y (2026). [PMID: 41742683](https://pubmed.ncbi.nlm.nih.gov/41742683/). *Cancer Sci*. [Basic Science / Preclinical]
Elsayad AM (2026). [PMID: 41839688](https://pubmed.ncbi.nlm.nih.gov/41839688/). *J Genet Eng Biotechnol*. [Clinical Trial Publication]
Unknown (2026). [PMID: 42150011](https://pubmed.ncbi.nlm.nih.gov/42150011/). *Unknown Journal*. [Review / Meta-Analysis]
Tong Y (2026). [PMID: 41383256](https://pubmed.ncbi.nlm.nih.gov/41383256/). *Exp Ther Med*. [Epidemiology / Natural History]
Song J (2026). [PMID: 42056683](https://pubmed.ncbi.nlm.nih.gov/42056683/). *Cancer Med*. [Basic Science / Preclinical]
Tan Y (2026). [PMID: 41858102](https://pubmed.ncbi.nlm.nih.gov/41858102/). *Neuropsychopharmacol Rep*. [Epidemiology / Natural History]
Zhang HH (2026). [PMID: 42271454](https://pubmed.ncbi.nlm.nih.gov/42271454/). *Cell Commun Signal*. [Basic Science / Preclinical]
Lao Z (2026). [PMID: 41995080](https://pubmed.ncbi.nlm.nih.gov/41995080/). *Elife*. [Basic Science / Preclinical]
Park M (2026). [PMID: 42232602](https://pubmed.ncbi.nlm.nih.gov/42232602/). *Oncol Res*. [Epidemiology / Natural History]
Saltan N (2026). [PMID: 42197262](https://pubmed.ncbi.nlm.nih.gov/42197262/). *Molecules*. [Basic Science / Preclinical]